BMA to support High Court challenge against CSA

The BMA is compiling evidence on members' experiences of the CSA exam to support a judicial review that will assess whether the test discriminates against international medical graduates.

Dr Krishna Kasaraneni: BMA will compile evidence to support judicial review
Dr Krishna Kasaraneni: BMA will compile evidence to support judicial review

The British Association of Physicians of Indian Origin (BAPIO) has been granted a judicial review over the fairness of the clinical skills assessment part of the MRCGP exams.

Both the RCGP and the GMC are named defendants in the case, which is expected to be heard next year.

BMA GP trainee subcommittee chairman Dr Krishna Kasaraneni said in a statment released on 24 October that the BMA had had a 'a very positive and constructive meeting with BAPIO today about their CSA legal case'.

He added: ‘Following our discussions, the BMA plans to draft an impact statement which can form a part of BAPIO's evidence in its judicial review case. We will also be asking our members to submit their own individual impact statements detailing how they have been affected by the CSA exam. In the next few weeks we will continue to discuss how we can further support BAPIO.

‘The profession and the public need to have confidence in the way exams are run and our members should be confident that competition is fair. If there is a risk of bias, measures must be taken to address this.’

According to a report commissioned by the GMC, the failure rate for first CSA attempts is 4.5% for white UK candidates and 17.1% for UK BME candidates. For international medical graduates, the failure rate is 47.7% for white candidates and for 65.2% for BME candidates. For white EU candidates, the failure rate is 32.3% and for BME EU candidates, it is 68.8%.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in